|
Gene Amplification Technologies: End Users, Marketers, and MarketsPublished by: Kalorama Information Published: Aug. 1, 2002 - 156 Pages Special Offer. Now 25% off the original price of $3000.Table of ContentsChapter One: Executive Summary
Table 2-2: Comparison of RCAT with PCR by Feature Table 2-3: Summary of Isothermal & Cycling Gene Amplification Technologies Table 2-4: Advantages/Disadvantages of Isothermal and Cycling DNA Amplification Techniques Table 2-5: Advantages & Disadvantages: Exponential versus Linear DNA Amplification Techniques Table 2-6: Gene Amplification Technologies Physical Characteristic and Development Date Summary Table 2-7: Range, Sensitivity & Specificity Gene Amplification Properties Table 2-8: Amplification Technology Research-Only Companies Table 2-9: Amplification Technology Application-Only Companies Table 2-10: Amplification Technology Research & Application Companies Table 3-1: Gene Amplification Technology Sales Table 3-2: Gene Amplification Technology Market Share by Competitor Table 3-3: Target vs. Signal Gene Amplification Technology Revenue Table 3-4: Cycling vs Isothermal Gene Amplification Technology Revenue Table 3-5: Exponential vs Linear Gene Amplification Technology Revenue Table 4-1: Technology Used in FDA Approved Molecular Diagnostic Tests Table 4-2: FDA-Approved Clinical Molecular Diagnostic Test by Technology and Company Table 4-3: PCR FDA-Approved Molecular Diagnostic Tests and Companies Table 4-4: TMA FDA-Approved Molecular Diagnostic Tests and Companies Table 4-5: Hybrid Capture FDA-Approved Molecular Diagnostic Tests and Companies Table 4-6: NASBA FDA-Approved Molecular Diagnostic Tests and Companies Table 4-7: FDA-Approved Clinical Molecular Diagnostic Tests by Disease Table 4-8: FDA-Approved Chlamydia Tests Table 4-9: FDA-Approved Gonorrhea Tests Table 4-10: FDA-Approved HIV & HCV Tests
AbstractGene amplification technology has been a backbone technology for the Human Genome Project and is vital in other fields, such as diagnostics. There are more than 50 biotech and diagnostic companies with DNA amplification technology and approximately 30 different gene- and signal-amplification technologies, from polymerase chain reaction to ligase chain reaction, transcription mediated amplification, and dendritic polymers. And these many technologies are being used for an ever-increasing variety of applications in research and clinical settings.The market for amplification technology is currently in the hundreds of millions of dollars, but as the need for information about genes in genomics and other research progresses, and as clinical diagnostic tools develop, the market for amplification technology will continue to grow. Although PCR is currently the dominant amplification technology, other technologies are emerging to challenge PCR in many areas. Patents, costs, and ease of use of a technique are forces that drive the development of amplification technology and will shape this dynamic market.
This study reviews the landscape in this emerging sector, discussing technologies, applications, competitors, and regulation. In addition, Kalorama has conducted the first ever end-user survey, to determine the preferences of actual researchers using various amplification technologies in various settings and for various applications.
|
|
|||
|
About MarketResearch.com
|
||||